Fennec Pharmaceuticals (FENC) Change in Account Payables (2014 - 2025)
Fennec Pharmaceuticals (FENC) posted Change in Account Payables of -$1.2 million for Q4 2025, down 1541.33% on a QoQ basis from -$75000.0 in Q3 2025, and down 96.65% year-over-year from -$36.7 million in Q4 2024.
Fennec Pharmaceuticals (FENC) Change in Account Payables (2014 - 2025) Analysis & Trends
Fennec Pharmaceuticals' Change in Account Payables history runs 12 years deep, the most recent figure standing at -$1.2 million for Q4 2025.
- Quarterly Change in Account Payables fell 96.65% year-over-year to -$1.2 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.4 million (up 359.59% YoY) and the FY2025 annual result came in at $1.4 million, up 359.59% from the prior year.
- Change in Account Payables was -$1.2 million for Q4 2025 at Fennec Pharmaceuticals, down from -$75000.0 in the prior quarter.
- Across five years, Change in Account Payables topped out at $2.0 million in Q1 2025 and bottomed at -$1.8 million in Q2 2021.
- A 5-year average of $153150.0 and a median of $252500.0 in 2022 frame the typical range for Change in Account Payables.
- Annual changes were most pronounced in 2021 — Change in Account Payables jumped 1387.3% — and 2024, when it tumbled 1405.17%.
- Fennec Pharmaceuticals' Change in Account Payables stood at -$377000.0 in 2021, then jumped by 61.8% to -$144000.0 in 2022, then surged by 681.25% to $837000.0 in 2023, then plunged by 174.79% to -$626000.0 in 2024, then slumped by 96.65% to -$1.2 million in 2025.
- Business Quant data shows FENC's Change in Account Payables at -$1.2 million in Q4 2025, -$75000.0 in Q3 2025, and $661000.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Fennec Pharmaceuticals | 346.75 Mn | 309.97 Mn | 12.01 Mn | -1.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.23 Mn |
| Dec 31, 2025 | -1.23 Mn |
| Sep 30, 2025 | -75,000.00 |
| Sep 30, 2025 | -75,000.00 |
| Jun 30, 2025 | 661,000.00 |
| Jun 30, 2025 | 661,000.00 |
| Mar 31, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.04 Mn |
| Dec 31, 2024 | -626,000.00 |
| Dec 31, 2024 | -626,000.00 |
| Sep 30, 2024 | -580,000.00 |
| Sep 30, 2024 | -580,000.00 |
| Jun 30, 2024 | -757,000.00 |
| Jun 30, 2024 | -757,000.00 |
| Mar 31, 2024 | 1.43 Mn |
| Mar 31, 2024 | 1.43 Mn |
| Dec 31, 2023 | 837,000.00 |
| Dec 31, 2023 | 837,000.00 |
| Sep 30, 2023 | -64,000.00 |
| Sep 30, 2023 | -64,000.00 |